RAMM Pharma Corp.
RAMM
CNSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 91.44% | -1,058.85% | 43.21% | 24.72% | 40.18% |
| Total Depreciation and Amortization | -17.33% | -8.20% | -2.36% | -0.74% | 38.90% |
| Total Amortization of Deferred Charges | 233.33% | -200.00% | -- | -- | -- |
| Total Other Non-Cash Items | -100.24% | 5,865.68% | -252.44% | -87.16% | -65.98% |
| Change in Net Operating Assets | -65.47% | 590.04% | -208.61% | 2,411.11% | 75.48% |
| Cash from Operations | 58.73% | 47.29% | -10.19% | 13.67% | 9.09% |
| Capital Expenditure | -10.00% | -75.82% | -9,000.00% | 98.96% | 75.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 10.71% | 81.88% | -173.92% | 91.74% |
| Cash from Investing | 16.19% | -42.86% | 52.43% | -195.96% | -62.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 26.57% | -47.68% | -0.35% | -2.84% | 39.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 392.86% | 48.15% | -- | -- |
| Cash from Financing | 1.12% | 7.82% | 10.99% | -30.94% | 2.80% |
| Foreign Exchange rate Adjustments | 488.89% | -25.00% | -61.90% | 163.00% | -146.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 53.83% | 43.77% | -7.07% | 6.78% | 0.48% |